Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Sales of Kiniksa Pharmaceuticals’ biggest product, Arcalyst, are expected to begin declining in 2030. But the company has a plan.
The post Kiniksa’s Sales Are Expected To Decline — Why That’s All According To Plan appeared first on Investor’s Business Daily.
